COMPREHENSIVE PATENT PROTECTION

Matrix Biomed, Inc.’s legal team, directed by world renowned intellectual property expert Ned Israelsen, includes some of the most notable and respected leaders in the field of intellectual property and patent prosecution including K&L Gates, Knobbe Martens, and Mohr Intellectual Property Law Solutions, P.C. This team provides support and strategic development for obtaining a patent portfolio that has resulted in exclusive control over the administration of MTS-01, MBM-01, and MBM-02

Matrix Biomed, Inc.’s innovative drug discovery and development strategy represents the forefront of pharmaceutical development delivering a more focused and directed product capable of addressing the multifactorial nature of many human diseases. These drug products are directed to address both the dysregulation of multiple genes as well as their interactions in gene regulatory networks.  Only by addressing the dysregulation of multiple genes and their interactions in gene regulatory networks, Matrix Biomed, Inc. is able to deliver a therapy designed to truly revert a disease state to healthy state.

Matrix Biomed, Inc. discovers novel therapeutic relationships between drugs and disease conditions by conducting a comprehensive and systematic comparison of drug and disease gene expression signatures through various gene array studies.  Matrix Biomed, Inc.’s patent procurement strategy and USPTO granted claims provide a much broader population group compared with industry standard patents, through the modulation of gene expressions that can be applied to a multitude of diseases and conditions.